Here we go again.
Researchers at Sirtis (owned by Glaxo-SmithKline) are testing a new diet drug that would allow the couch potatoes of the world to eat whatever they want and never gain an ounce.
Wait, it gets better.
It would also rid the planet of Type 2 Diabetes.
It gets even better.
They are developing other versions that promise to extend the average life span while preventing heart disease, cancer and Alzheimer’s disease.
Wow!
This sounds great…Tell me more.
OK
This particular drug, SRT1720, fools the body into thinking food is scarce and it has to burn off fat to survive.
It does this by triggering a protein called SIRT1 that plays a key role in regulating the body’s supply of energy.
So how did they come up with the idea for this wonder drug?
Researchers discovered the importance of the SIRT1 protein by studying the metabolic effects shown by the natural supplement, Resveratrol.
But where Resveratrol affects many other systems in the body, SRT1720 targets “only the SIRT1 pathway, making it more selective and potent for achieving these metabolic benefits”.
Oh, and because it is a synthetic substance, designed by a pharmaceutical company, it can be patented.
And make billions and billions of dollars.
I wonder how the GSK execs reacted to that bit of good news.
But wait, let’s be fair here. It’s not like they could just produce a high dose Resveratrol supplement at 1/4 the price while still maintaining all of the heart healthy, anti-cancer, anti-Alzheimer’s effects.
Oh, wait a second.
Oh well, that’s the HEALTH CARE business.
.
If you like what you see here, click here for updates or Share this Post with the rest of the world.
.
Related Posts
- New Diet Drug Offers An Alternative To Obesity Surgery
- Wanna Lose Weight?…Here Comes Big Pharma’s Newest and Bestest Magic Bullet
- How To Reverse The Effects Of Type 2 Diabetes
- 4 Steps To A Great HIIT Workout
- Why Can’t I Lose This Fat?
Popularity: 1% [?]
